Roche leads pre-JPM deal spree; Roger Perlmutter’s new pharma force; Inside Sage’s big triumph and failure; Late Friday IPO filings; All new drugs in 2023; and more
Welcome to the first issue of Endpoints Weekly in 2024! The year is starting strong, and there will be no shortage of topics for my …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
